Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 74

1.

Systematic analysis of therapeutic patterns and healthcare use during 12 months before inflammatory bowel disease-related hospitalization in Switzerland.

Schoepfer A, Vavricka SR, Brüngger B, Blozik E, Bähler C.

Eur J Gastroenterol Hepatol. 2020 Mar;32(3):350-357. doi: 10.1097/MEG.0000000000001616.

PMID:
31834046
2.

Pharmaceutically treated comorbidities and associated healthcare costs among triptan users in Switzerland: A pharmacoepidemiological study from a nationwide health insurance database.

Huber CA, Agosti R, Näpflin M, Blozik E.

Pharmacoepidemiol Drug Saf. 2019 Dec 11. doi: 10.1002/pds.4938. [Epub ahead of print]

PMID:
31828875
3.

Coverage rates and timeliness of nationally recommended vaccinations in Swiss preschool children: A descriptive analysis using claims data.

Schneider R, Reinau D, Schur N, Blozik E, Früh M, Signorell A, Heininger U, Schwenkglenks M, Meier CR.

Vaccine. 2020 Feb 5;38(6):1551-1558. doi: 10.1016/j.vaccine.2019.11.057. Epub 2019 Nov 30.

PMID:
31791812
4.

Opioid Prescription in Switzerland: Appropriate Comedication use in Cancer and Noncancer Pain.

Wertli MM, Held U, Signorell A, Steurer J, Blozik E, Burgstaller JM.

Pain Physician. 2019 Nov;22(6):537-548.

5.

Real-World Data on Topical Therapies and Annual Health Resource Utilization in Hospitalized Swiss Patients with Ulcerative Colitis.

Baehler C, Brüngger B, Blozik E, Vavricka SR, Schoepfer AM.

Inflamm Intest Dis. 2019 Oct;4(4):144-153. doi: 10.1159/000502205. Epub 2019 Aug 7.

6.

Quality of life assessment in patients with heart failure: validity of the German version of the generic EQ-5D-5L™.

Boczor S, Daubmann A, Eisele M, Blozik E, Scherer M.

BMC Public Health. 2019 Nov 6;19(1):1464. doi: 10.1186/s12889-019-7623-2.

7.

Drug prescription patterns, polypharmacy and potentially inappropriate medication in Swiss nursing homes: a descriptive analysis based on claims data.

Schneider R, Reinau D, Schur N, Blozik E, Früh M, Signorell A, Meier CR, Schwenkglenks M.

Swiss Med Wkly. 2019 Sep 30;149:w20126. doi: 10.4414/smw.2019.20126. eCollection 2019 Sep 23.

8.

Treatment patterns in patients using triptan and prophylactic medication: an analysis of clinical practice prior to the introduction of CGRP antagonists.

Huber CA, Agosti R, Näpflin M, Blozik E.

J Pain Res. 2019 Jul 19;12:2211-2221. doi: 10.2147/JPR.S207606. eCollection 2019.

9.

Hospital readmission risk prediction based on claims data available at admission: a pilot study in Switzerland.

Brüngger B, Blozik E.

BMJ Open. 2019 Jun 29;9(6):e028409. doi: 10.1136/bmjopen-2018-028409.

10.

Antidepressant prescription practice and related factors in Switzerland: a cross-sectional analysis of health claims data.

Haller E, Watzke B, Blozik E, Rosemann T, Reich O, Huber CA, Wolf M.

BMC Psychiatry. 2019 Jun 24;19(1):196. doi: 10.1186/s12888-019-2178-4.

11.

Measuring diabetes guideline adherence with claims data: systematic construction of indicators and related challenges.

Ulyte A, Bähler C, Schwenkglenks M, von Wyl V, Gruebner O, Wei W, Blozik E, Brüngger B, Dressel H.

BMJ Open. 2019 Apr 24;9(4):e027138. doi: 10.1136/bmjopen-2018-027138.

12.

Post-myocardial Infarction (MI) Care: Medication Adherence for Secondary Prevention After MI in a Large Real-world Population.

Huber CA, Meyer MR, Steffel J, Blozik E, Reich O, Rosemann T.

Clin Ther. 2019 Jan;41(1):107-117. doi: 10.1016/j.clinthera.2018.11.012. Epub 2018 Dec 24.

PMID:
30591287
13.

Variation of preoperative chest radiography utilization in Switzerland and its influencing factors: a multilevel study with claims data.

Wei W, Gruebner O, von Wyl V, Brüngger B, Dressel H, Ulyte A, Blozik E, Bähler C, Schwenkglenks M.

Sci Rep. 2018 Nov 30;8(1):17475. doi: 10.1038/s41598-018-35856-9.

14.

Evidence-based indicators for the measurement of quality of primary care using health insurance claims data in Switzerland: results of a pragmatic consensus process.

Blozik E, Reich O, Rapold R, Scherer M; Swiss Quality Indicator for Primary Care (SQIPRICA) Working Group.

BMC Health Serv Res. 2018 Sep 27;18(1):743. doi: 10.1186/s12913-018-3477-z.

15.

Systematic analysis of annual health resource utilization and costs in hospitalized patients with inflammatory bowel disease in Switzerland.

Schoepfer A, Vavricka SR, Brüngger B, Reich O, Blozik E, Bähler C.

Eur J Gastroenterol Hepatol. 2018 Aug;30(8):868-875. doi: 10.1097/MEG.0000000000001160.

PMID:
29757772
16.

Budget impact model for oncopharmacogenetics from the perspective of mandatory basic health insurance in Switzerland using the example of breast cancer.

Szucs TD, Szillat KP, Blozik E.

Pharmgenomics Pers Med. 2018 Apr 23;11:67-69. doi: 10.2147/PGPM.S154368. eCollection 2018.

17.

Intensity of treatment in Swiss cancer patients at the end-of-life.

Bähler C, Signorell A, Blozik E, Reich O.

Cancer Manag Res. 2018 Mar 15;10:481-491. doi: 10.2147/CMAR.S156566. eCollection 2018.

18.

Outcomes and costs of Ranibizumab and Aflibercept treatment in a health-service research context.

Schmid MK, Reich O, Blozik E, Faes L, Bodmer NS, Locher S, Thiel MA, Rapold R, Kuhn M, Bachmann LM.

BMC Ophthalmol. 2018 Feb 27;18(1):64. doi: 10.1186/s12886-018-0731-4.

19.

Glucocorticoids and the Risk of Peptic Ulcer Bleeding: Case-Control Analysis Based on Swiss Claims Data.

Reinau D, Schwenkglenks M, Früh M, Signorell A, Blozik E, Meier CR.

Drug Saf. 2018 Jul;41(7):725-730. doi: 10.1007/s40264-018-0645-3.

PMID:
29468603
20.

Importance of comorbidities in the treatment of primary care patients with heart failure-Baseline results of the observational RECODE-HF Study.

Eisele M, Adam W, Rakebrandt A, Boczor S, Blozik E, Träder JM, Störk S, Herrmann-Lingen C, Scherer M; RECODE-HF study group.

Fam Pract. 2018 Jul 23;35(4):481-487. doi: 10.1093/fampra/cmx135.

PMID:
29385434
21.

General practitioners' awareness of depressive symptomatology is not associated with quality of life in heart failure patients - cross-sectional results of the observational RECODE-HF Study.

Eisele M, Boczor S, Rakebrandt A, Blozik E, Träder JM, Störk S, Herrmann-Lingen C, Scherer M; RECODE-HF Study Group.

BMC Fam Pract. 2017 Dec 8;18(1):100. doi: 10.1186/s12875-017-0670-9.

22.

Injections frequency and health care costs in patients treated with aflibercept compared to ranibizumab: new real-life evidence from Switzerland.

Reich O, Schmid MK, Rapold R, Bachmann LM, Blozik E.

BMC Ophthalmol. 2017 Dec 4;17(1):234. doi: 10.1186/s12886-017-0617-x.

23.

Epidemiology and costs of multiple sclerosis in Switzerland: an analysis of health-care claims data, 2011-2015.

Blozik E, Rapold R, Eichler K, Reich O.

Neuropsychiatr Dis Treat. 2017 Nov 1;13:2737-2745. doi: 10.2147/NDT.S143180. eCollection 2017.

24.

Factors associated with general practitioners' awareness of depression in primary care patients with heart failure: baseline-results from the observational RECODE-HF study.

Eisele M, Rakebrandt A, Boczor S, Kazek A, Pohontsch N, Okolo-Kulak M, Blozik E, Träder JM, Störk S, Herrmann-Lingen C, Scherer M; RECODE Study Group.

BMC Fam Pract. 2017 Jun 9;18(1):71. doi: 10.1186/s12875-017-0641-1.

25.

Medical Overuse in Switzerland: How Frequent is Preoperative Chest Radiography?

Blozik E, Brüngger B, Reich O.

Praxis (Bern 1994). 2017;106(7):343-349. doi: 10.1024/1661-8157/a002628. German. No abstract available.

PMID:
28357906
26.

The Patient Enrolled in a Managed Care Insurance Plan or the Physician Being Part of a Network: What Drives the Efficiency Gain?

Reich O, Rapold R, Blozik E.

Praxis (Bern 1994). 2017;106(7):351-358. doi: 10.1024/1661-8157/a002640. German. No abstract available.

PMID:
28357898
27.

How does hospitalization affect continuity of drug therapy: an exploratory study.

Blozik E, Signorell A, Reich O.

Ther Clin Risk Manag. 2016 Aug 22;12:1277-83. doi: 10.2147/TCRM.S109214. eCollection 2016.

28.

Impact of a community pharmacist-led medication review on medicines use in patients on polypharmacy--a prospective randomised controlled trial.

Messerli M, Blozik E, Vriends N, Hersberger KE.

BMC Health Serv Res. 2016 Apr 23;16:145. doi: 10.1186/s12913-016-1384-8.

29.

Bridging the gap between patient needs and quality indicators: a qualitative study with chronic heart failure patients.

Baudendistel I, Noest S, Peters-Klimm F, Herzberg H, Scherer M, Blozik E, Joos S.

Patient Prefer Adherence. 2015 Sep 30;9:1397-405. doi: 10.2147/PPA.S83850. eCollection 2015.

30.

Prescription of potentially inappropriate medication in older persons in Switzerland: does the dispensing channel make a difference?

Blozik E, Rapold R, Reich O.

Risk Manag Healthc Policy. 2015 Apr 24;8:73-80. doi: 10.2147/RMHP.S78179. eCollection 2015.

31.

[Patient Participation in Development of Quality Indicators using the Example of National Disease Management Guidelines for Chronic Heart Failure - A Qualitative Analysis of Collective Perspectives].

Herzberg H, Bernateck K, Welti F, Joos S, Pohontsch NJ, Blozik E, Scherer M.

Gesundheitswesen. 2016 Jun;78(6):373-7. doi: 10.1055/s-0035-1548880. Epub 2015 May 7. German.

PMID:
25951114
32.

Health care utilization and expenditures in persons receiving social assistance in 2012: evidence from Switzerland.

Reich O, Wolffers F, Signorell A, Blozik E.

Glob J Health Sci. 2014 Dec 16;7(4):1-11. doi: 10.5539/gjhs.v7n4p1.

33.

Metamizole-associated adverse events: a systematic review and meta-analysis.

Kötter T, da Costa BR, Fässler M, Blozik E, Linde K, Jüni P, Reichenbach S, Scherer M.

PLoS One. 2015 Apr 13;10(4):e0122918. doi: 10.1371/journal.pone.0122918. eCollection 2015. Review.

34.

The professional perspective on patient involvement in the development of quality indicators: a qualitative analysis using the example of chronic heart failure in the German health care setting.

Pohontsch NJ, Herzberg H, Joos S, Welti F, Scherer M, Blozik E.

Patient Prefer Adherence. 2015 Jan 22;9:151-9. doi: 10.2147/PPA.S74064. eCollection 2015.

35.

Potentially inappropriate medication use in older patients in Swiss managed care plans: prevalence, determinants and association with hospitalization.

Reich O, Rosemann T, Rapold R, Blozik E, Senn O.

PLoS One. 2014 Aug 19;9(8):e105425. doi: 10.1371/journal.pone.0105425. eCollection 2014.

36.

Instruments to assess patient satisfaction after teleconsultation and triage: a systematic review.

Allemann Iseli M, Kunz R, Blozik E.

Patient Prefer Adherence. 2014 Jun 24;8:893-907. doi: 10.2147/PPA.S56160. eCollection 2014.

37.

[Promotion of next generation primary care physicians: initiatives in the university training of medical students].

Blozik E, Ehrhardt M, Scherer M.

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2014 Jul;57(7):892-902. doi: 10.1007/s00103-014-1984-6. German.

PMID:
24950838
38.

[Comorbidity in medical guidelines: comparison of the current state, epidemiologic models and expert opinion].

Blozik E, Dubben HH, Wagner HO, Scherer M.

Z Evid Fortbild Qual Gesundhwes. 2014;108(4):219-28. doi: 10.1016/j.zefq.2014.02.001. Epub 2014 Mar 28. German.

PMID:
24889711
39.

Fundoplication versus medical management of gastroesophageal reflux disease: systematic review and meta-analysis.

Blozik E.

Surg Endosc. 2014 Jul;28(7):2249. doi: 10.1007/s00464-014-3437-6. Epub 2014 May 23. No abstract available.

PMID:
24853836
40.

Diagnostic utility of a one-item question to screen for depressive disorders: results from the KORA F3 study.

Blozik E, Scherer M, Lacruz ME, Ladwig KH; KORA study group.

BMC Fam Pract. 2013 Dec 23;14:198. doi: 10.1186/1471-2296-14-198.

41.

Screening for mental disorders in heart failure patients using computer-adaptive tests.

Fischer HF, Klug C, Roeper K, Blozik E, Edelmann F, Eisele M, Störk S, Wachter R, Scherer M, Rose M, Herrmann-Lingen C.

Qual Life Res. 2014 Jun;23(5):1609-18. doi: 10.1007/s11136-013-0599-y. Epub 2013 Dec 14.

PMID:
24338104
42.
43.

Teleconsultation in children with abdominal pain: a comparison of physician triage recommendations and an established paediatric telephone triage protocol.

Staub GM, von Overbeck J, Blozik E.

BMC Med Inform Decis Mak. 2013 Sep 30;13:110. doi: 10.1186/1472-6947-13-110.

44.

Epidemiological strategies for adapting clinical practice guidelines to the needs of multimorbid patients.

Blozik E, van den Bussche H, Gurtner F, Schäfer I, Scherer M.

BMC Health Serv Res. 2013 Sep 16;13:352. doi: 10.1186/1472-6963-13-352.

45.

Fundoplication versus medical management of gastroesophageal reflux disease: systematic review and meta-analysis.

Rickenbacher N, Kötter T, Kochen MM, Scherer M, Blozik E.

Surg Endosc. 2014 Jan;28(1):143-55. doi: 10.1007/s00464-013-3140-z. Epub 2013 Sep 10. Review. Erratum in: Surg Endosc. 2014 Jun;28(6):2002.

PMID:
24018760
46.

Involving patients in quality indicator development - a systematic review.

Kötter T, Schaefer FA, Scherer M, Blozik E.

Patient Prefer Adherence. 2013;7:259-68. doi: 10.2147/PPA.S39803. Epub 2013 Mar 27.

47.

Polypharmacy and potentially inappropriate medication in the adult, community-dwelling population in Switzerland.

Blozik E, Rapold R, von Overbeck J, Reich O.

Drugs Aging. 2013 Jul;30(7):561-8. doi: 10.1007/s40266-013-0073-0.

PMID:
23553511
48.

Simultaneous development of guidelines and quality indicators -- how do guideline groups act? A worldwide survey.

Blozik E, Nothacker M, Bunk T, Szecsenyi J, Ollenschläger G, Scherer M.

Int J Health Care Qual Assur. 2012;25(8):712-29.

PMID:
23276064
50.

[Improvements in survival in patients with heart failure].

Blozik E, Eisele M, Scherer M.

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2012 Apr;55(4):552-7. doi: 10.1007/s00103-012-1456-9. German.

PMID:
22441525

Supplemental Content

Loading ...
Support Center